Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Microangiopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00593229
What this trial is testing

International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

Who this might be right for
Thrombotic MicroangiopathyHemolytic Uremic SyndromeThrombotic Thrombocytopenic Purpura
Northwell Health 6
Not applicableStudy completedNCT02002091
What this trial is testing

Morbidity in Newly Diagnosed type2 Diabetes in Adults

Who this might be right for
Type2 Diabetes MellitusComplications
University of Algiers 327
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05684159
What this trial is testing

Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy

Who this might be right for
aHUS - Atypical Hemolytic Uremic Syndrome
NovelMed Therapeutics 12
Large-scale testing (Phase 3)Looking for participantsNCT05795140
What this trial is testing

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 65
Not applicableNot Yet RecruitingNCT07705789
What this trial is testing

The Role of interferOn and Complement in SecondAry thRombotic micrioangiOpathy

Who this might be right for
Thrombotic Microangiopathies
Sofie Dhaese 40
Not applicableUnknownNCT01126775
What this trial is testing

Neuro-Prävention im Rahmen Des Interventionsprojektes INVADE-2 (Follow-up Studie)

Who this might be right for
StrokeDementia
INVADE gGmbH 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05855083
What this trial is testing

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Who this might be right for
Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation
Omeros Corporation 18
Large-scale testing (Phase 3)Ended earlyNCT04784455
What this trial is testing

Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy

Who this might be right for
Thrombotic Microangiopathies
AKARI Therapeutics 10
Not applicableUnknownNCT02220257
What this trial is testing

The Influence of Partial Remission Phase of Type 1 Diabetes on Patient Outcome

Who this might be right for
Diabetes Mellitus Type 1Remission of Type 1 DiabetesChronic Complications of Diabetes
Poznan University of Medical Sciences 140
Not applicableLooking for participantsNCT06715046
What this trial is testing

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy 30
Large-scale testing (Phase 3)Study completedNCT04557735
What this trial is testing

Study of Ravulizumab in Pediatric Participants With HSCT-TMA

Who this might be right for
Thrombotic Microangiopathy
Alexion Pharmaceuticals, Inc. 41
Testing effectiveness (Phase 2)WithdrawnNCT03303313
What this trial is testing

An Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alnylam Pharmaceuticals
Not applicableUnknownNCT06098378
What this trial is testing

Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab

Who this might be right for
Thrombotic Microangiopathies
University Hospital, Strasbourg, France 30
Testing effectiveness (Phase 2)Looking for participantsNCT07707687
What this trial is testing

Safety and Efficacy of Eculizumab in High-risk TA-TMA

Who this might be right for
Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
First Affiliated Hospital of Zhejiang University 24
Not applicableStudy completedNCT02610036
What this trial is testing

Obliterating Diabetic Microangiopathy of the Diabetic Foot

Who this might be right for
Diabetic Foot
IRCCS Multimedica 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05504187
What this trial is testing

Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Kira Pharmacenticals (US), LLC. 24
Not applicableStudy completedNCT01865604
What this trial is testing

Impact of tDCS on Cerebral Autoregulation

Who this might be right for
Cerebral MicroangiopathyCADASILMigraine With Aura+1 more
Charite University, Berlin, Germany 60
Not applicableLooking for participantsNCT05634928
What this trial is testing

Construction of a Database for TMA

Who this might be right for
Thrombotic Microangiopathies
The First Affiliated Hospital of Soochow University 500
Not applicableLooking for participantsNCT06376786
What this trial is testing

Italian iTTP Registry

Who this might be right for
TTP - Thrombotic Thrombocytopenic Purpura
Fondazione Luigi Villa 132
Next Page